Loading…

RORγt inhibitors suppress T(H)17 responses in inflammatory arthritis and inflammatory bowel disease

Saved in:

Bibliographic Details
Published in:	Journal of allergy and clinical immunology 2016-03, Vol.137 (3), p.960
Main Authors:	de Wit, Jelle, Al-Mossawi, M Hussein, Hühn, Michael H, Arancibia-Cárcamo, Carolina V, Doig, Karen, Kendrick, Benjamin, Gundle, Roger, Taylor, Peter, Mcclanahan, Terri, Murphy, Erin, Zhang, Hongjun, Barr, Ken, Miller, J Richard, Hu, Xiao, Aicher, Thomas D, Morgan, Rodney W, Glick, Gary D, Zaller, Dennis, Correll, Craig, Powrie, Fiona, Bowness, Paul
Format:	Article
Language:	English
Subjects:	Arthritis - drug therapy Arthritis - genetics Arthritis - immunology Arthritis - metabolism Gene Expression Regulation - drug effects Humans Indazoles - chemistry Indazoles - pharmacology Inflammatory Bowel Diseases - drug therapy Inflammatory Bowel Diseases - genetics Inflammatory Bowel Diseases - immunology Inflammatory Bowel Diseases - metabolism Interleukin-17 - biosynthesis Nuclear Receptor Subfamily 1, Group F, Member 3 - antagonists & inhibitors T-Lymphocyte Subsets - drug effects T-Lymphocyte Subsets - immunology T-Lymphocyte Subsets - metabolism Th17 Cells - drug effects Th17 Cells - immunology Th17 Cells - metabolism
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!